Skip to main content
. Author manuscript; available in PMC: 2014 Aug 14.
Published in final edited form as: J Pharm Sci. 2012 May 11;101(8):2763–2776. doi: 10.1002/jps.23180

Table 1.

Selection of complexing ion for remote loading of gefitinib

Complexing
ion
Gefitinib mM
±s.d.
Phospholipid mM
±s.d.
Drug:Lipid Ratio
±s.d.
Initial Final Initial Final Initial Final
Citrate 2.21 ±0.23 0.87 ±0.02 10.50 ±0.30 5.55 ±0.67 0.21 ±0.03 0.16 ±0.02 *
Ammonium Sulfate 2.12 ±0.24 1.08 ±0.26 11.39 ±0.34 5.69 ±0.12 0.19 ±0.02 0.19 ±0.04
Tris/NaCl 4.59 ±1.88 0.23 ±0.01 18.35 ±0.67 7.67 ±0.29 0.25 ±0.11 0.03 ±0.002 *
Free Drug 1.51 ±0.78 0.25 ±0.01 - -

s.d.: standard deviation

n=triplicate determinations for each sample

*

Decreased significantly from initial value (p<0.05)